A potent MAPK13–14 inhibitor prevents airway inflammation and mucus production

Common respiratory diseases continue to represent a major public health problem, and much of the morbidity and mortality is due to airway inflammation and mucus production. Previous studies indicated a role for mitogen-activated protein kinase 14 (MAPK14) in this type of disease, but clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Keeler, Shamus P., Wu, Kangyun, Zhang, Yong, Mao, Dailing, Li, Ming, Iberg, Courtney A., Austin, Stephen R., Glaser, Samuel A., Yantis, Jennifer, Podgorny, Stephanie, Brody, Steven L., Chartock, Joshua R., Han, Zhenfu, Byers, Derek E., Romero, Arthur G., Holtzman, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246002/
https://www.ncbi.nlm.nih.gov/pubmed/37292761
http://dx.doi.org/10.1101/2023.05.26.542451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246002/
https://www.ncbi.nlm.nih.gov/pubmed/37292761
http://dx.doi.org/10.1101/2023.05.26.542451

Ejemplares similares